The core activity of Indivi is the development and integration of innovative digital solutions for the research and treatment of neuroimmunological and neurodegenerative diseases, particularly multiple sclerosis. The company works closely with the Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) to advance the development of precision medicine and personalized treatment approaches.
AI-generated
Offering
Products & services
Industry:Research & Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Digital biomarkers and endpoints for neurological research
Digital biomarkers and measurement instruments for multiple sclerosis, Parkinson's, Alzheimer's and related dementias; objective collection of movement, cognition, vision, balance, dexterity and voice.
Clinical trial platform for neurology
Clinical trial platform with Indivi App, Indivi Cloud and Indivi PRO; data capture across multiple devices and apps, secure transmission, quality checks and analysis for pharma, CROs and academia.
End-to-end development of digital endpoints
End-to-end support from protocol creation through adaptive interim analyses to statistical evaluation and reporting for RCTs and digital endpoints.
Quality assurance and data management for digital measurements
Signal verification, data quality checks, test execution analysis, feature extraction as well as secure data transfer, storage, processing and monitoring.